The aim of this study was to investigate the effect of either ω-3+ω-6 PUFAs or ω-3 only in a CCL2−/− animal model that shares some of the clinical features of human AMD,34 while monitoring the AA/EPA ratio (~1–1.5). Here, CCL2 is linked to age-related macular degeneration.